CD4 and Stroke: Moreover, intravenous albumin administration reduced Toll-like receptor 4 expression but significantly increased FoxP3+CD25+CD4+ Tregs expression levels and elevated IL-10 and TGF-β1 production, eventually conferring neuroprotective effects during postischemic stroke treatment [93].